Dupilumab
Abstract
Concept set to identify patients with dupilumab treatment to define a study cohort.
Affiliation(s)
Funder(s)
Provenance
This concept set was developed for the study on Incidence of Autoimmune Diseases in Children with Atopy Treated with Dupilumab to define a cohort of patients with atopic disease (moderate-to-severe asthma or atopic dermatitis) who were treated with dupilumab.
Description
This concept set was developed by a data scientist (KH) for a study led by CHOP clinicians Dr. Jonathan Spergel and Dr. Stan Gabryszewski, to investigate dupilumab use and autoimmune diseases in patients with asthma and atopic dermatitis. The codeset is designed for use with the PEDSnet data model. Using RxNav, the RxCUI codes for the drug dupilumab and its corresponding Clinical Dose Form Group and Clinical Drug Form codes were identified. Descendant codes were subssequently obtained, not limited by vocabulary.
Vocabulary
Related Publications
Creative Commons license
Except where otherwised noted, this item's license is described as a CC-BY Attribution 4.0 license.